Your browser doesn't support javascript.
loading
Transferability of Alzheimer Disease Polygenic Risk Score Across Populations and Its Association With Alzheimer Disease-Related Phenotypes.
Jung, Sang-Hyuk; Kim, Hang-Rai; Chun, Min Young; Jang, Hyemin; Cho, Minyoung; Kim, Beomsu; Kim, Soyeon; Jeong, Jee Hyang; Yoon, Soo Jin; Park, Kyung Won; Kim, Eun-Joo; Yoon, Bora; Jang, Jae-Won; Kim, Yeshin; Hong, Jin Yong; Choi, Seong Hye; Noh, Young; Kim, Ko Woon; Kim, Si Eun; Lee, Jin San; Jung, Na-Yeon; Lee, Juyoun; Lee, Ae Young; Kim, Byeong C; Cho, Soo Hyun; Cho, Hanna; Kim, Jong Hun; Jung, Young Hee; Lee, Dong Young; Lee, Jae-Hong; Lee, Eek-Sung; Kim, Seung Joo; Moon, So Young; Son, Sang Joon; Hong, Chang Hyung; Bae, Jin-Sik; Lee, Sunghoon; Na, Duk L; Seo, Sang Won; Cruchaga, Carlos; Kim, Hee Jin; Won, Hong-Hee.
Afiliação
  • Jung SH; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Kim HR; Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Chun MY; Department of Neurology, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Republic of Korea.
  • Jang H; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Cho M; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim B; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim S; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
  • Jeong JH; Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Yoon SJ; Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Park KW; Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Kim EJ; Department of Neurology, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Republic of Korea.
  • Yoon B; Department of Neurology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Republic of Korea.
  • Jang JW; Department of Neurology, Dong-A University College of Medicine, Department of Translational Biomedical Sciences, Graduate School of Dong-A University, Busan, Republic of Korea.
  • Kim Y; Department of Neurology, Pusan National University Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Republic of Korea.
  • Hong JY; Department of Neurology, Konyang University College of Medicine, Daejeon, Republic of Korea.
  • Choi SH; Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, Republic of Korea.
  • Noh Y; Department of Neurology, Kangwon National University Hospital, Kangwon National University College of Medicine, Chuncheon, Republic of Korea.
  • Kim KW; Department of Neurology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Kim SE; Department of Neurology, Inha University School of Medicine, Incheon, Republic of Korea.
  • Lee JS; Department of Neurology, Gachon University College of Medicine, Gil Medical Center, Incheon, Republic of Korea.
  • Jung NY; Department of Neurology, School of Medicine, Jeonbuk National University Hospital, Jeonju, Republic of Korea.
  • Lee J; Department of Neurology, Inje University College of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea.
  • Lee AY; Department of Neurology, Kyung Hee University College of Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.
  • Kim BC; Department of Neurology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine and Medical Research Institute, Busan, Republic of Korea.
  • Cho SH; Department of Neurology, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Cho H; Department of Neurology, Chungnam National University Hospital, Daejeon, Republic of Korea.
  • Kim JH; Departmet of Neurology, Chonnam National University School of Medicine, Gwangju, Republic of Korea.
  • Jung YH; Departmet of Neurology, Chonnam National University School of Medicine, Gwangju, Republic of Korea.
  • Lee DY; Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lee JH; Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.
  • Lee ES; Department of Neurology, Myongji Hospital, Hanyang University, Goyang, Republic of Korea.
  • Kim SJ; Department of Psychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
  • Moon SY; Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
  • Son SJ; Department of Neurology, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea.
  • Hong CH; Department of Neurology, Gyeongsang National University School of Medicine and Gyeongsang National University Changwon Hospital, Changwon, Republic of Korea.
  • Bae JS; Department of Neurology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Lee S; Department of Psychiatry, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Na DL; Department of Psychiatry, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Seo SW; Eone-Diagnomics Genome Center (EDGC), Incheon, Republic of Korea.
  • Cruchaga C; Eone-Diagnomics Genome Center (EDGC), Incheon, Republic of Korea.
  • Kim HJ; Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Won HH; Alzheimer's Disease Convergence Research Center, Samsung Medical Center, Seoul, Republic of Korea.
JAMA Netw Open ; 5(12): e2247162, 2022 12 01.
Article em En | MEDLINE | ID: mdl-36520433
ABSTRACT
Importance Polygenic risk scores (PRSs), which aggregate the genetic effects of single-nucleotide variants identified in genome-wide association studies (GWASs), can help distinguish individuals at a high genetic risk for Alzheimer disease (AD). However, genetic studies have predominantly focused on populations of European ancestry.

Objective:

To evaluate the transferability of a PRS for AD in the Korean population using summary statistics from a prior GWAS of European populations. Design, Setting, and

Participants:

This cohort study developed a PRS based on the summary statistics of a large-scale GWAS of a European population (the International Genomics of Alzheimer Project; 21 982 AD cases and 41 944 controls). This PRS was tested for an association with AD dementia and its related phenotypes in 1634 Korean individuals, who were recruited from 2013 to 2019. The association of a PRS based on a GWAS of a Japanese population (the National Center for Geriatrics and Gerontology; 3962 AD cases and 4074 controls) and a transancestry meta-analysis of European and Japanese GWASs was also evaluated. Data were analyzed from December 2020 to June 2021. Main Outcomes and

Measures:

Risk of AD dementia, amnestic mild cognitive impairment (aMCI), earlier symptom onset, and amyloid ß deposition (Aß).

Results:

A total of 1634 Korean patients (969 women [59.3%]), including 716 individuals (43.6%) with AD dementia, 222 (13.6%) with aMCI, and 699 (42.8%) cognitively unimpaired controls, were analyzed in this study. The mean (SD) age of the participants was 71.6 (9.0) years. Higher PRS was associated with a higher risk of AD dementia independent of APOE ɛ4 status in the Korean population (OR, 1.95; 95% CI, 1.40-2.72; P < .001). Furthermore, PRS was associated with aMCI, earlier symptom onset, and Aß deposition independent of APOE ɛ4 status. The PRS based on a transancestry meta-analysis of data sets comprising 2 distinct ancestries showed a slightly improved accuracy. Conclusions and Relevance In this cohort study, a PRS derived from a European GWAS identified individuals at a high risk for AD dementia in the Korean population. These findings emphasize the transancestry transferability and clinical value of PRSs and suggest the importance of enriching diversity in genetic studies of AD.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Alzheimer Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article